1015 15th Street, N.W., 6th Floor
Washington, DC 20005
On April 8, 2013, Hudson Institute’s Initiative on Future Innovation convened a distinguished panel of experts from business, science, public health, law, and the academic world for an off-the-record workshop on a working draft of Reclaiming Innovation in the Life Sciences: Reform FDA, Modernize its Culture by Scott Gottlieb and Tevi Troy Dr. Gottlieb is a physician and resident fellow at the American Enterprise Institute, and formerly served as deputy commissioner of the Food and Drug Administration. Mr. Troy is a visiting fellow at Hudson Institute and former deputy secretary of the U.S. Department of Health and Human Services. Reclaiming Innovation in the Life Sciences — which will be published in final form as the fourth in a series of major research papers by Hudson’s Innovation Initiative, and thereafter available for download on this page — is a careful analysis of procedural rules and regulatory guidelines governing FDA review of proposed new medical treatments and pharmaceutical products, and a prescription for major reform of that system in the interests of improved public health and economic efficiency.
Join Hudson for a discussion with Sir Iain on the economic, political, and security measures the US and its allies need to take to defeat the rising authoritarian axis.
Join Keystone Defense Initiative Director Rebeccah Heinrichs for a conversation with Hammer about the book and the future of US-Israel relations.
Former policymakers and leading national security experts will join Hudson to assess how China’s growing influence is reshaping the regional order—and how the US should respond.
Join Hudson for a panel that will examine some of the tools that could help revitalize US investment in the region, including development finance, political risk insurance, and economic innovation zones.
